JP Morgan Chase
RXDX

JP Morgan Chase’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

JP Morgan Chase’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$10.9M Sell
2022
Q4 		$14M Buy
2022
Q3 		$4.84M Sell
2022
Q2 		$2.33M Sell
2022
Q1 		$3.13M Buy
2021
Q4 		$591K Buy
2021
Q3 		$103K Sell
2021
Q2 		$168K Buy